Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Novome Biotechnologies

Request full access

Operates in the technology industry

San Francisco, United StatesFounded 2016Biotech & Life Sciences

About Novome Biotechnologies

Novome Biotherapeutics is a biotech startup that specializes in engineering cell therapies to combat chronic diseases. The company operates in the healthcare market, specifically in the field of synthetic biology and microbiome therapeutics. Novome's unique approach involves the use of Genetically Engineered Microbial Medicines (GEMMs), which are microbes engineered to colonize the gut and perform specific therapeutic activities.

The company's business model revolves around the development and commercialization of these GEMMs. The microbes are designed to colonize the gut for an extended period, with their abundance maintained and adjusted through a daily dose of a prebiotic polysaccharide. This approach allows for sustained and effective therapies for chronic diseases.

Novome's primary clients are patients suffering from chronic diseases, who stand to benefit from their innovative therapies. The company generates revenue through the development, clinical testing, and eventual sale of these therapies.

Their lead program, NOV-001, has already demonstrated safety and controllable engraftment in a Phase 1 study involving healthy volunteers. This therapy is currently being studied further, indicating the company's progress in bringing its innovative solutions to market.

In summary, Novome Biotherapeutics is a pioneering biotech company that leverages synthetic biology to engineer cell therapies, offering a novel approach to treating chronic diseases.

Source: Dealroom company data

At a glance

Status
Operational
Employees
1
Open positions
None listed
Dealroom signal
61.3/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotechnology, Microbiology, Synthetic Biology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Sep 2022 $44M $174M Alexandria Venture Investments · Touchdown Ventures · Navian Investment Group · Colorcon Ventures ↗
SERIES AOther financing Jan 2020 $33M $132M Alta Partners · DCVC · 5AM Ventures · Alexandria Venture Investments —
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Novome Biotechnologies website traffic

Latest recorded traffic for Novome Biotechnologies is 270 monthly website visits, down 37.2% over the last three months. Novome Biotechnologies's team grew 0% over the past year.

Latest monthly visits270 3-month web change-37.2% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Novome Biotechnologies in the San Francisco ecosystem

Live from Dealroom

The Novome Biotechnologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • 5AM Ventures
  • US National Science Foundation

Series A8 investors entered at this stage

  • DCVC
  • Alta Partners
  • Alexandria Venture Investments
  • Tencent
  • Touchdown Ventures
  • Navian Investment Group
  • Colorcon Ventures
  • University of Minnesota Twin Cities

Other known investors1 additional known investor

  • Stanford University
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Novome Biotechnologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Novome Biotechnologies’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.